Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FJ4ZY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $115,010
Award facts
- Contract value 100% obligated
- $115,009.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded September 16, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides $115,009.66 in firm fixed-price pharmaceutical supplies. The order specifically covers Biktarvy 50-200-25 mg tablets in quantities of 30 units, an antiretroviral medication used in HIV treatment. The award represents a non-competitive delivery order placed against AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 and extending through December 2026. No set-aside designation applies to this award. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 17, 2025.
AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, leverages its comprehensive IDC to fulfill critical medical supply needs across the Defense Health System. The company's extensive portfolio encompasses brand-name and generic pharmaceuticals, vaccines, and specialized medical commodities supporting military healthcare operations globally. This delivery order exemplifies the contractor's ongoing role as a key vendor in the federal pharmaceutical supply chain, enabling the DLA to rapidly procure essential medications for military treatment facilities and beneficiaries worldwide.
Quick answers
Who was awarded contract SPE2DB25FJ4ZY?
SPE2DB25FJ4ZY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FJ4ZY worth?
The government has obligated $115,010 on SPE2DB25FJ4ZY.
Is contract SPE2DB25FJ4ZY an order under another contract?
Yes. SPE2DB25FJ4ZY is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ4ZY competed?
The extent of competition for SPE2DB25FJ4ZY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award